David G. Fernig

15.4k total citations · 3 hit papers
211 papers, 12.1k citations indexed

About

David G. Fernig is a scholar working on Molecular Biology, Cell Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David G. Fernig has authored 211 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Molecular Biology, 81 papers in Cell Biology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David G. Fernig's work include Proteoglycans and glycosaminoglycans research (75 papers), Fibroblast Growth Factor Research (60 papers) and Glycosylation and Glycoproteins Research (35 papers). David G. Fernig is often cited by papers focused on Proteoglycans and glycosaminoglycans research (75 papers), Fibroblast Growth Factor Research (60 papers) and Glycosylation and Glycoproteins Research (35 papers). David G. Fernig collaborates with scholars based in United Kingdom, France and China. David G. Fernig's co-authors include Nguyễn Thị Kim Thanh, Wolfgang Haiss, Jenny Aveyard, Philip S. Rudland, Raphaël Lévy, Mark C. Wilkinson, Mathias Brust, John T. Gallagher, Jeremy E. Turnbull and Chris Doty and has published in prestigious journals such as Journal of the American Chemical Society, Physical Review Letters and Chemical Society Reviews.

In The Last Decade

David G. Fernig

209 papers receiving 11.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Determination of Size and Concentration of Gold Nanoparticles from UV−Vis Spectra

2007 3.1k citations David G. Fernig et al. profile →
Rational and Combinatorial Design of Peptide Capping Ligands for Gold Nanoparticles

2004 621 citations Raphaël Lévy, David G. Fernig et al. profile →
A rapid method to estimate the concentration of citrate capped silver nanoparticles from UV-visible light spectra

2014 621 citations David G. Fernig et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David G. Fernig United Kingdom	51	6.3k	2.7k	2.6k	2.3k	2.2k	211	12.1k
Yan Geng China	55	6.3k 1.0×	2.3k 0.9×	1.2k 0.5×	1.8k 0.8×	419 0.2×	256	15.0k
Longping Wen China	51	4.4k 0.7×	2.4k 0.9×	604 0.2×	1.9k 0.8×	925 0.4×	139	9.7k
Fuyuhiko Tamanoi United States	68	9.1k 1.4×	3.4k 1.3×	1.9k 0.7×	3.1k 1.3×	450 0.2×	215	16.4k
Daniel I. C. Wang United States	44	3.9k 0.6×	2.0k 0.8×	659 0.3×	2.5k 1.1×	1.2k 0.5×	107	8.0k
Susumu Uchiyama Japan	46	4.8k 0.8×	1.0k 0.4×	596 0.2×	793 0.3×	1.1k 0.5×	437	9.1k
Wei He China	49	4.5k 0.7×	2.4k 0.9×	365 0.1×	2.4k 1.1×	802 0.4×	248	11.3k
Xiaohong Fang China	58	7.8k 1.2×	2.9k 1.1×	508 0.2×	4.1k 1.8×	537 0.2×	236	12.5k
Daniel A. Hammer United States	71	6.6k 1.0×	2.2k 0.8×	5.5k 2.1×	5.4k 2.3×	317 0.1×	279	21.0k
Min Wu China	59	7.4k 1.2×	2.1k 0.8×	758 0.3×	3.4k 1.5×	194 0.1×	294	14.8k
Min Zhou China	52	5.0k 0.8×	1.3k 0.5×	463 0.2×	752 0.3×	842 0.4×	194	9.8k

Countries citing papers authored by David G. Fernig

Since Specialization

Citations

This map shows the geographic impact of David G. Fernig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Fernig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Fernig more than expected).

Fields of papers citing papers by David G. Fernig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Fernig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Fernig. The network helps show where David G. Fernig may publish in the future.

Co-authorship network of co-authors of David G. Fernig

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Fernig. A scholar is included among the top collaborators of David G. Fernig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Fernig. David G. Fernig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Shiyu, Qiqi Wang, Wenjuan Luo, et al.. (2025). Histones are critical toxic factors in gut lymph of severe acute pancreatitis: Neutralization by baicalin and baicalein for protection. Phytomedicine. 139. 156474–156474.

Supungul, Premruethai, et al.. (2025). Effects of the sulfated polysaccharides dextran sulfate and heparin on shrimp immunity and infection by white spot syndrome virus and Vibrio parahaemolyticus. Aquaculture Reports. 42. 102735–102735.

Li, Yong, et al.. (2024). Identification of heparin-binding amino acid residues in antibody HS4C3 with the potential to design antibodies against heparan sulfate domains. Glycobiology. 34(8). 1 indexed citations

Lima, Marcelo A., et al.. (2023). History and Prospects for the Sustainability and Circularity of the Windowpane Oyster Placuna placenta Fishery in the Philippines. Fishes. 8(10). 493–493. 2 indexed citations

Mycroft‐West, Courtney J., Scott E. Guimond, Patricia Procter, et al.. (2023). A sulphated glycosaminoglycan extract from Placopecten magellanicus inhibits the Alzheimer's disease β-site amyloid precursor protein cleaving enzyme 1 (BACE-1). Carbohydrate Research. 525. 108747–108747. 2 indexed citations

Byrne, Dominic P., et al.. (2022). Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicity. Biochemical Journal. 479(24). 2511–2527. 4 indexed citations

Li, Yong, Sarah H. Hewitt, Edwin A. Yates, et al.. (2021). Anion binding to a cationic europium( iii ) probe enables the first real-time assay of heparan sulfotransferase activity. Organic & Biomolecular Chemistry. 20(3). 596–605. 8 indexed citations

Nunes, Quentin, Dunhao Su, Philip Brownridge, et al.. (2019). The heparin-binding proteome in normal pancreas and murine experimental acute pancreatitis. PLoS ONE. 14(6). e0217633–e0217633. 26 indexed citations

Mycroft‐West, Courtney J., Patricia Procter, Scott E. Guimond, et al.. (2019). A Glycosaminoglycan Extract from Portunus pelagicus Inhibits BACE1, the β Secretase Implicated in Alzheimer’s Disease. Marine Drugs. 17(5). 293–293. 9 indexed citations

10.

Byrne, Dominic P., Yong Li, Igor Barsukov, et al.. (2018). New tools for carbohydrate sulfation analysis: heparan sulfate 2- O -sulfotransferase (HS2ST) is a target for small-molecule protein kinase inhibitors. Biochemical Journal. 475(15). 2417–2433. 17 indexed citations

11.

Byrne, Dominic P., Yong Li, Claire E. Eyers, et al.. (2018). New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors. Biochemical Journal. 475(15). 2435–2455. 28 indexed citations

12.

Li, Yong, Changye Sun, Edwin A. Yates, et al.. (2016). Heparin binding preference and structures in the fibroblast growth factor family parallel their evolutionary diversification. Open Biology. 6(3). 150275–150275. 52 indexed citations

13.

Sun, Changye, Marco Marcello, Yong Li, et al.. (2016). Selectivity in glycosaminoglycan binding dictates the distribution and diffusion of fibroblast growth factors in the pericellular matrix. Open Biology. 6(3). 150277–150277. 22 indexed citations

14.

Connell, Marilyn G., Toin H. Van Kuppevelt, Ruoyan Xu, et al.. (2011). Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation?. BMC Developmental Biology. 11(1). 38–38. 11 indexed citations

15.

Fernig, David G., Edwin C. Jesudason, Paul D. Losty, et al.. (2009). Heparan Sulfate Phage Display Antibodies Identify Distinct Epitopes with Complex Binding Characteristics. Journal of Biological Chemistry. 284(51). 35621–35631. 33 indexed citations

16.

Delehedde, Maryse, et al.. (2005). Heparan Sulphate. Kluwer Academic Publishers eBooks. 480. 65–69. 1 indexed citations

17.

Delehedde, Maryse, Michel Sève, Nicolas Sergeant, et al.. (2000). Fibroblast Growth Factor-2 Stimulation of p42/44MAPKPhosphorylation and IκB Degradation Is Regulated by Heparan Sulfate/Heparin in Rat Mammary Fibroblasts. Journal of Biological Chemistry. 275(43). 33905–33910. 64 indexed citations

18.

Fernig, David G., Hailan Chen, Hassan Rahmoune, et al.. (2000). Differential Regulation of FGF-1 and -2 Mitogenic Activity Is Related to Their Kinetics of Binding to Heparan Sulfate in MDA-MB-231 Human Breast Cancer Cells. Biochemical and Biophysical Research Communications. 267(3). 770–776. 26 indexed citations

19.

Rahmoune, Hassan, Jeremy E. Turnbull, J T Gallagher, Philip S. Rudland, & David G. Fernig. (1996). HEPARAN SULPHATE IN BREAST CANCER CELLS. Biochemical Society Transactions. 24(3). 355S–355S. 6 indexed citations

20.

Chen, Hailan, John A. Smith, Philip S. Rudland, & David G. Fernig. (1996). Potentiation of the growth-stimulatory effects of aFGF by heparin in Rama 27 fibroblasts. Biochemical Society Transactions. 24(3). 358S–358S. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact